Navigation Links
Boston Scientific Announces Results for First Quarter Ended March 31, 2008
Date:4/21/2008

or excluding each

of these individual items:

-- Acquisition-related charges -- These adjustments primarily consist of

purchased research and development, integration costs associated with

the Company's acquisition of Guidant, and a fair value adjustment

related to the sharing of proceeds feature of the Abbott stock

purchase. Purchased research and development is a highly variable

charge based on valuation assumptions. Management removes the impact of

purchased research and development from the Company's operating results

to assist in assessing the Company's operating performance and cash

generated from operations. The integration costs associated with the

Company's acquisition of Guidant do not reflect expected on-going

future operating expenses. The fair value adjustment related to the

sharing of proceeds feature of the Abbott stock purchase is a non-cash

adjustment and is not indicative of the Company's on-going operations.

Accordingly, management excluded these charges for purposes of

calculating these non-GAAP measures to facilitate an evaluation of the

Company's current operating performance and a comparison to the

Company's past operating performance.

-- Gain on divestitures -- These gains are not indicative of future

operating performance and are not used by management to assess

operating performance. Accordingly, management excluded these amounts

for purposes of calculating these non-GAAP measures to facilitate an

evaluation of the Company's current operating performance and a

comparison to the Company's past operating performance.

-- Restructuring-related charges -- These adjustments primarily represent

employee-related termination benefits, asset write-downs and other

costs associated with the Company's restructuring initiati
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 With only 2 weeks left ... on Sartorius Biohit products . The product specials include ... Electronic Pipette Trade-in Program, and free pipette tips. , ... around the world. They are ideal for lab technicians ... ,     Full volume range of 0.1 uL ...
(Date:12/19/2014)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced the results of its annual general meeting ... transformational year in Relmada,s history and it set the ... Sergio Traversa , chief executive officer of Relmada. ... financial, human resource and clinical development objectives that position ...
(Date:12/17/2014)... Achim Noack has been named global vice president ... position, Noack will assist Jerry Stoller, CEO and president ... and supervise global marketing management and implementation of new ... and experience in the crop protection industry,” says Jerry ... thinking will be a great asset for Stoller Group, ...
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2
... deCODE genetics (Nasdaq: DCGN ) and academic colleagues ... journal Nature Genetics the discovery of common genetic ... with fair and dark complexions alike. deCODE had previously discovered ... genome (SNPs) linked to risk of BCC, the most common ...
... Europe have united to build the largest quantum key ... research and industrial organisations were realised as secure, quantum ... network. With an average link length of 20 ... kilometres, the researchers from organisations such as the AIT ...
... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ... has been completed in the Phase II component of ... paclitaxel/carboplatin for patients with advanced cancers. The principal investigators ... Institute of Cancer Research, London, England, and Dr. Geoff ...
Cached Biology Technology:It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer 2It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer 3It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer 4Researchers unite to distribute quantum keys 2Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial 2
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
(Date:11/21/2014)... 2014   Atmel® Corporation (NASDAQ: ... touch technology solutions, today launched the industry,s first family ... widest V cc range from 1.7V to 5.5V. ... I 2 C bus communication speeds, and are available ... them ideal for consumer, industrial, computer, and medical applications. ...
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... is available in German . Many ... that numbers more than 680 different species. After initial invasion, ... switch to a highly destructive life-style, feeding on dead cells. ... stealthy and destructive modes simultaneously. A team of scientists led ...
... of Naval Research (ONR) were honored with Presidential Early ... highest honor for young scientists and engineers, officials announced ... individuals underscores ONR,s fundamental objective, which is to bring ... of the best and brightest minds the nation has ...
... Institute of Tropical Medicine have breathed new life into ... tuberculosis in circumstances where so far this was hardly ... major antibiotics are a serious threat to world health. ... action, ,multiresistant tuberculosis, may become a worldwide epidemic, wiping ...
Cached Biology News:Differences in the genomes of related plant pathogens 2Differences in the genomes of related plant pathogens 3ONR-funded young innovators recognized by President 2New approach of resistant tuberculosis 2New approach of resistant tuberculosis 3
...
...
... cytostatic and anti-viral agent. Inhibits several important steps ... formation of HUVEC cells. Also reduces intracellular reactive ... IL-8 release of endothelial cells. ... 16 O 8 MolWeight: ...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Biology Products: